Anaplastic Oligoastrocytoma Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global Industry Analysis<br />
and Forecast 2016 - 2024<br />
Persistence <strong>Market</strong> Research<br />
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global<br />
Industry Analysis and Forecast 2016 - 2024<br />
Persistence <strong>Market</strong> Research 1
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global Industry Analysis<br />
and Forecast 2016 - 2024<br />
Persistence <strong>Market</strong> Research Released New <strong>Market</strong> Report on “<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong><br />
<strong>Market</strong> : Global Industry Analysis and Forecast 2016 - 2024”.<br />
<strong>Oligoastrocytoma</strong>s is a part of a group of brain tumor called “gliomas”. Glioma tumor is<br />
originated in the brain or spine. <strong>Oligoastrocytoma</strong>s contains both astrocytoma cells and<br />
oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as<br />
oligoastrocytomas. <strong>Oligoastrocytoma</strong>s is divided into two parts, low grade and anaplastic.<br />
According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as<br />
grade 1 and grade 2 but sometimes they appear to be grade 4. <strong>Anaplastic</strong> oligoastrocytomas<br />
can be characterized by high cellularity, conspicuous cytologic atypism, microvascular<br />
proliferation, mitotic activity and necrosis. Patients suffering from this condition show symptoms<br />
like headache, seizure and speech or motor changes. According to the American Brain Cancer<br />
Association, clinical trials for the treatment of this tumor are in process to minimize the<br />
recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or<br />
chemotherapy and radiation therapy session.<br />
Interested in report: Please follow the below links to meet your requirements; Request<br />
for the Report Sample: http://www.persistencemarketresearch.com/samples/10502<br />
<strong>Anaplastic</strong> oligoastrocytomas market is offers potential opportunities to cancer care industry.<br />
Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric<br />
population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical<br />
trials for novel drug development. Moreover factors such as advancement in technology and<br />
innovations in diangositc techniques is expected to drive the growth of anaplastic<br />
oligoastrocytoma market over the forecast period. However, lack of specific treatment and<br />
critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic<br />
oligoastrocytomas market.<br />
Persistence <strong>Market</strong> Research 2
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global Industry Analysis<br />
and Forecast 2016 - 2024<br />
Basically the treatment of anaplastic oligoastrocytoma depends on the size of the tumor. The<br />
treatment is processed by surgery to remove the tumor. In order to eliminate the cancerous<br />
cells, the combinational therapies such as chemotherapy or radiation therapy are used as<br />
effective treatment for anaplastic oligoastrocytoma.<br />
Request TOC (table of content), Figures and Tables of the Report:<br />
http://www.persistencemarketresearch.com/toc/10502<br />
<strong>Anaplastic</strong> oligoastrocytoma market is segmented on basis of treatment Type, end user<br />
and region:<br />
By Treatment Type<br />
• Chemotherapy<br />
• Radiation<br />
By End Use<br />
• Hospitals<br />
• Cancer Centers<br />
• Surgical Centers<br />
<strong>Oligoastrocytoma</strong>s is most common in adults and generally occurs at the age of 35–50.<br />
Generally these type of tumors are found in both the genders. Children of age 0-14 are often<br />
diagnosed with oligoastrocytomas and these tumors comprises of only three percent of primary<br />
brain tumors. Factors such as increasing demand for treatment therapies for anaplastic<br />
oligoastrocytoma, increasing prevalence of anaplastic oligoastrocytoma in emerging economies<br />
are expected provide traction to the growth of anaplastic oligoastrocytoma over the forecast<br />
period (2016-2026)<br />
Persistence <strong>Market</strong> Research 3
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global Industry Analysis<br />
and Forecast 2016 - 2024<br />
On the basis of region presence, anaplastic oligoastrocytoma market is segmented into five key<br />
regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The<br />
North America and Europe market are at maturity level for clinical research of treatment for<br />
anaplastic oligoastrocytomas. <strong>Market</strong>s of Asia-Pacific region have also shown keen interest in<br />
clinical trials of this tumor and are showing growth at faster pace, due to increasing incidence of<br />
anaplastic oligoastrocytoma.<br />
Following are the companies and institutions which are involved in clinical trials of treatment for<br />
anaplastic oligoastocytomas are Tocagen, Inc., Shandong Lanjin Pharmaceuticals Co. Ltd,<br />
Keryx Biopharmaceuticals, Inc., Biogen Idec, Inc., Insys Therapeutics, Inc, Rush University<br />
Medical Center and University of California, San Diego.<br />
The report covers exhaustive analysis on:<br />
• <strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> Segments<br />
• <strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> Dynamics<br />
• Historical Actual <strong>Market</strong> Size, 2013 - 2015<br />
• <strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> Size & Forecast 2016 to 2022<br />
• <strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> Current Trends/Issues/Challenges<br />
• Competition & Companies involved<br />
• <strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> Drivers and Restraints<br />
Regional analysis includes<br />
Persistence <strong>Market</strong> Research 4
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global Industry Analysis<br />
and Forecast 2016 - 2024<br />
• North America<br />
• Latin America<br />
• Europe<br />
• Asia Pacific<br />
• Middle East & Africa<br />
Report Highlights:<br />
• Shifting Industry dynamics<br />
• In-depth market segmentation<br />
• Historical, current and projected industry size Recent industry trends<br />
• Key Competition landscape<br />
• Strategies of key players and product offerings<br />
• Potential and niche segments/regions exhibiting promising growth<br />
• A neutral perspective towards market performance<br />
About Us:<br />
Persistence <strong>Market</strong> Research (PMR) is a full-service market intelligence firm specializing in<br />
syndicated research, custom research, and consulting services. PMR boasts market research<br />
expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and<br />
Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping<br />
and Transportation industries. The company draws from its multi-disciplinary capabilities and<br />
high-pedigree team of analysts to share data that precisely corresponds to clients’ business<br />
needs.<br />
Persistence <strong>Market</strong> Research 5
<strong>Anaplastic</strong> <strong>Oligoastrocytoma</strong> <strong>Market</strong> : Global Industry Analysis<br />
and Forecast 2016 - 2024<br />
PMR stands committed to bringing more accuracy and speed to clients’ business decisions.<br />
From ready-to-purchase market research reports to customized research solutions, PMR’s<br />
engagement models are highly flexible without compromising on its deep-seated research<br />
values.<br />
Contact Us:<br />
Persistence <strong>Market</strong> Research<br />
305 Broadway<br />
7th Floor, New York City,<br />
NY 10007, United States,<br />
USA - Canada Toll Free: 800-961-0353<br />
Email: sales@persistencemarketresearch.com<br />
Web: http://www.persistencemarketresearch.com<br />
Persistence <strong>Market</strong> Research 6
Change language